Corbus Pharmaceuticals Holdings (CRBP) Amortizatization of Intangibles (2020 - 2024)

Corbus Pharmaceuticals Holdings' (CRBP) quarterly Amortizatization of Intangibles came in at $76000.0 in Q3 2024, down 62.75% year-on-year from $204000.0 in Q4 2023, and down 42.42% quarter-over-quarter from $132000.0 in Q2 2024.

Corbus Pharmaceuticals Holdings (CRBP) Amortizatization of Intangibles (2020 - 2024) Analysis & Trends

Corbus Pharmaceuticals Holdings' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $76000.0 for Q3 2024.

  • On a quarterly basis, Amortizatization of Intangibles fell 62.75% year-over-year to $76000.0 in Q3 2024; TTM through Jun 2025 was $76000.0, a 89.36% decrease from a year earlier, with the FY2024 full-year figure at $396000.0, down 51.94% from the prior year.
  • Amortizatization of Intangibles slipped to $76000.0 in Q3 2024 per CRBP's latest filing, from $132000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $343193.0 in Q2 2021 and bottomed at $901.0 in Q1 2021.
  • The 5-year median for Amortizatization of Intangibles is $185201.5 (2022), against an average of $177219.1.
  • Across the five-year window, Amortizatization of Intangibles jumped 19533.85% in 2022 and slumped 62.75% in 2024, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $172415.0 in 2020, then tumbled by 45.17% to $94535.0 in 2021, then jumped by 114.32% to $202611.0 in 2022, then retreated by 6.22% to $190000.0 in 2023, then sank by 60.0% to $76000.0 in 2024.
  • Per Business Quant, the three latest CRBP Amortizatization of Intangibles figures stand at $76000.0 (Q3 2024), $132000.0 (Q2 2024), and $188000.0 (Q1 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Corbus Pharmaceuticals Holdings 112.73 Mn 84.92 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 76,000.00
Sep 30, 2024 76,000.00
Jun 30, 2024 132,000.00
Jun 30, 2024 132,000.00
Mar 31, 2024 188,000.00
Mar 31, 2024 188,000.00
Dec 31, 2023 190,000.00
Dec 31, 2023 190,000.00
Sep 30, 2023 204,000.00
Sep 30, 2023 204,000.00
Jun 30, 2023 228,877.00
Jun 30, 2023 228,877.00
Mar 31, 2023 201,123.00
Mar 31, 2023 201,123.00
Dec 31, 2022 202,611.00
Dec 31, 2022 202,611.00
Sep 30, 2022 182,403.00
Sep 30, 2022 182,403.00
Jun 30, 2022 180,563.00
Jun 30, 2022 180,563.00